Rousseau, A.-F., Ngongan, A., COLSON, C., MINGUET, P., NEIS GILSON, S., Cavalier, E., MINGUET, G., Misset, B., & Boemer, F. (16 August 2023). Mid-Term Evolution of the Serum Acylcarnitine Profile in Critically Ill Survivors: A Metabolic Insight into Survivorship. Nutrients, 15 (16), 3595. doi:10.3390/nu15163595 |
Joris, M., Pincemail, J., COLSON, C., JORIS, J., CALMES, D., Cavalier, E., Misset, B., Guiot, J., MINGUET, G., & Rousseau, A.-F. (25 July 2022). Exercise Limitation after Critical Versus Mild COVID-19 Infection: A Metabolic Perspective. Journal of Clinical Medicine, 11 (15), 4322. doi:10.3390/jcm11154322 |
Nyssen, P., Mouithys-Mickalad, A., MINGUET, G., Sauvage, E., Wouters, J., Franck, T., & Hoebeke, M. (October 2018). Morphine, a potential inhibitor of myeloperoxidase activity. Biochimica et Biophysica Acta - General Subjects, 1862 (10), 2236-2244. doi:10.1016/j.bbagen.2018.07.007 |
Nyssen, P., Mouithys-Mickalad, A., MINGUET, G., & Hoebeke, M. (05 December 2017). Study of the antioxidant action of two analgesic compounds, morphine and propofol, on the activity of MPO and HRP [Poster presentation]. Young Belgian Magnetic Resonance Scientist 2017, Blankenberge, Belgium. |
Hoebeke, M., Nyssen, P., Franck, T., MINGUET, G., Serteyn, D., & Mouithys-Mickalad, A. (20 May 2016). Study of the antioxidant action of morphine on the peroxidase cycle of MPO and HRP [Poster presentation]. 24th Benelux EPR society meeting, Liège, Belgium. |